Rare APOE3-R136S mutation offers protection against Alzheimer’s disease pathologies in new study

The R136S genetic mutation protected against apolipoprotein E4 (APOE4)-induced late-onset Alzheimer’s disease (LOAD).

Exclusive: Digital health venture firm Define Ventures hires industry vet Frank Williams

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Define Ventures has hired longtime Evolent Health

April 10, 2024

IU Cancer Center awarded grant to train next generation of cancer drug discovery researchers

The Indiana University Melvin and Bren Simon Comprehensive Cancer Center was awarded a prestigious grant to train the next generation of cancer drug discovery and

October 10, 2023

Retinal Injections May Increase Risk for Cataract Surgery Complications

CHICAGO — Retinal injections for eye disease had a significant association with increased complications rates after cataract surgery, according to a large retrospective cohort study.

October 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.